[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ana Rita Londral, PhD\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":4},"100611176",false,"NCT07237178","PROMBot-HSM-FA: Protocol for a Feasibility Study of a Chatbot Platform to Collect Patient-reported Outcomes After AF Ablation","PROMBot-HSM-FA: Protocol for a Feasibility Study of a Chatbot-based Platform to Collect Patient-reported Outcomes After Atrial Fibrillation Ablation","PROMBot-HSM-FA","Inclusion Criteria:\n\n* age 18 years or older;\n* documented diagnosis of paroxysmal or persistent AF based on clinical assessment and coded according to the International Classification of Diseases, 11th Revision;\n* undergone catheter ablation for AF at Hospital de Santa Marta during the study recruitment period;\n* able to use the PROMBot-FA chatbot independently or with caregiver assistance, defined as Portuguese literacy sufficient to understand instructions and ability to operate a smartphone;\n* clinically stable at discharge with no acute post-procedural complications precluding participation; and\n* provision of written informed consent.\n\nExclusion Criteria:\n\n* severe cognitive impairment preventing comprehension of study procedures, such as moderate-to-severe dementia or other neurological conditions limiting capacity to consent;\n* severe uncorrected visual impairment or motor disability preventing smartphone operation even with caregiver support;\n* explicit refusal to use digital technology or unwillingness to share health data required for the study;\n* clinical or contextual conditions rendering 3-month follow-up unfeasible, including anticipated relocation outside the hospital catchment area or concurrent participation in another interventional study with overlapping endpoints; or\n* life expectancy less than 6 months.","ALL","18 Years",{"count":19,"type":20},76,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to learn if using a WhatsApp-based chatbot called PROMBot-FA can help people recover after atrial fibrillation ablation. The main questions it aims to answer are:\n\n* Is the chatbot easy and practical for people to use after their procedure?\n* Do people find the chatbot helpful for sharing their symptoms and health updates?\n\nResearchers will compare follow-up care supported by the chatbot to standard hospital follow-up visits. Participants will:\n\n* Be randomly assigned to either use the chatbot or receive usual follow-up care.\n* Report their symptoms, well-being, and any problems after ablation for 3 months.\n* Complete short questionnaires about their experience using the chatbot.\n\nThis study will help researchers understand whether chatbot follow-up is feasible and acceptable for people after atrial fibrillation ablation and guide future larger studies.",[26,27],"Atrial Fibrillation (AF)","Catheter Ablation",[29,30,31,32,33],"atrial fibrillation","catheter ablation","postoperative care","telemedicine","Patient Reported Outcome Measures","NOT_YET_RECRUITING","2025-11-20",{"date":37,"type":38},"2025-11-26","ACTUAL",{"date":40,"type":20},"2025-12-01",{"date":42,"type":20},"2027-12",{"name":44,"class":45},"Ana Rita Londral, PhD","OTHER",""]